http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Jianxin He,Jiannan Lu,Liang Liu,Wu Yang,Haihua Yang,Pengpeng Chen,Xinyu Ding 대한토목학회 2024 KSCE Journal of Civil Engineering Vol.28 No.8
The primary contribution of this paper is to identify the optimal cross-section size and span diameter for large-grained hydraulic asphalt concrete materials in trabecular bending tests. First, three-point bending tests were conducted on asphalt concrete with maximum aggregate sizes of 19 mm (Dmax = 19 mm), 26.5 mm, and 31.5 mm, using six distinct cross-section sizes and span diameters. These experiments served to analyze the influence of varying cross-section sizes and span diameters on the mechanical properties of the materials. Secondly, the Image-Pro Plus (IPP) software was utilized to analyze and confirm the cross-sectional areas of the chosen samples. Then, by considering the optimal cross-section size and span diameter, the impact of temperature on the flexural characteristics of asphalt concrete with a maximum aggregate size of 31.5 mm was explored. This investigation enabled the proposal of a temperature cut-off interval governing the transformation of large-grained asphalt concrete from brittle to plastic damage. The validity of the experimental data was substantiated through image analysis, providing a benchmark for the testing methodology of the flexural performance of large-grained hydraulic asphalt concrete aggregate.
Qiannan Guo,Runyao Wen,Bin Shao,Yudong Li,Xin Jin,Heran Deng,Jiannan Wu,Fengxi Su,Fengyan Yu 한국유방암학회 2018 Journal of breast cancer Vol.21 No.2
Purpose: The long non-coding RNA H19, a conservatively imprinted gene, acts as a molecular sponge for the let-7 family, which has been identified as a set of tumor suppressors. However, the combined prognostic value of H19 and let-7a signature in breast cancer patients remains unclear. Methods: In this research we assessed the prognostic value of the combined H19 and let-7a signature in breast cancer patients by retrospectively reviewing that data of 79 patients who underwent neoadjuvant chemotherapy; we also investigated the expression and function of H19 in breast cancer cell lines in vitro. Survival data were calculated using the Kaplan-Meier method and compared using the log-rank test. Univariate and multivariate survival analyses were conducted using the Cox proportional hazards regression method. As determined using X-tile, the optimal cutoff value for the risk score to assess progression-free survival (PFS) based on the combined signature was –0.1. Results: Patients with an overall positive treatment response had higher let-7a and lower H19 levels. In addition, let-7a expression was negatively correlated with H19 expression. Patients with a risk score of >–0.1 had shorter overall survival and PFS. In vitro data showed that chemoresistant cell lines exhibit higher H19 and lower let-7a levels and knockdown H19 restores paclitaxel sensitivity. Conclusion: Our results suggest that the combined let-7a and H19 signature is a novel prognostic factor for breast cancer patients treated with neoadjuvant chemotherapy.